Resonance Health Ltd (ASX: RHT) Share Price and News

Price

$0.043

Movement

0.00 (0.0)

as at 11 Jun - Closed (20 mins delayed)

52 Week Range

$0.035 - $0.068

 
1 Year Return

-29.51%

Resonance Health Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $19.76 million
P/E Ratio 150.00
Dividend Yield 0.00%
Shares Outstanding 459.62 million
Earnings per share -0.001
Dividend per share N/A
Year To Date Return -23.08%
Earnings Yield 0.67%
Franking -
Share Price

$0.043

Day Change

0.00 (0.0)

52 Week Range

$0.035 - $0.068

Yesterday's Close

$0.043

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

92,529

Turnover

$0

as at 11 Jun - Closed

  • Resonance Health Ltd (ASX: RHT)
    Latest News

    Two kids in superhero capes.
    Small Cap Shares

    Guess which 2 ASX small-cap shares just rocketed 50%+ on big news!

    Investors are sending these two ASX small-cap stocks through the roof on Tuesday.

    Read more »

    Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
    Healthcare Shares

    Here's why the Resonance Health (ASX:RHT) share price is rocketing 36% today

    The company's shares are on fire. Here are the details

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Share Market News

    Here's why the Resonance Health (ASX:RHT) share price rocketed

    The Resonance Health share price rocketed more than 16% today before closing 5% higher. We take a look at what's…

    Read more »

    pause button on digital screen representing asx trading pause
    Share Market News

    Resonance Health (ASX:RHT) announces its share price is in trading halt

    The Resonance Health share price was edging higher today before the company announced that it would be entering a trading…

    Read more »

    rising ASX Telstra share price represented by man jumping in the air for joy looking at mobile phone
    Share Market News

    The Resonance Health (ASX:RHT) share price has rocketed up 9% today. Here's why.

    The Resonance Health (ASX: RHT) share price is soaring up today after the company announced a deal using its artificial…

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Share Market News

    Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today

    The Resonance Health Limited (ASX: RHT) share price is shooting 39% higher today after the company announced an important FDA…

    Read more »

    Share Gainers

    Why Afterpay, Creso Pharma, Healius, & Resonance Health shares are storming higher

    Afterpay Ltd (ASX:APT) and Healius Ltd (ASX:HLS) shares are two of four storming notably higher on Wednesday. Here's why...

    Read more »

    a woman
    Share Market News

    Here's why these 3 ASX shares are trading higher today

    Here are 3 ASX shares performing strongly today, providing some indication as to what's pushing the S&P/ASX 200 Index (INDEXASX:XJO)…

    Read more »

    a woman
    Share Market News

    Why the Resonance Health share price is rocketing 20% higher

    The Resonance Health Limited (ASX: RHT) share price has rocketed 20% after the company released an announcement this morning.

    Read more »

    a woman
    Investing

    The WORST investing mistake I've made recently

    A wise person learns from the mistakes of others...

    Read more »

    RHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    10th Jun 2025 2025-06-10T11:16:37 Launch of InvestorHubYesNo11:16am2275k
    29th Apr 2025 2025-04-29T09:40:42 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:40am91.5M
    10th Apr 2025 2025-04-10T10:09:59 Change of Director's Interest Notice - Aaron BrinkworthYesNo10:09am25.2k
    28th Feb 2025 2025-02-28T09:40:37 Half Year Results PresentationYesNo9:40am212.4M
    28th Feb 2025 2025-02-28T09:40:12 Half Year ResultsYesNo9:40am4518k
    28th Feb 2025 2025-02-28T09:22:12 Half Yearly Report and AccountsYesNo9:22am27853k
    21st Feb 2025 2025-02-21T08:17:26 Half Year Results - Call DetailsYesNo8:17am2271k
    28th Jan 2025 2025-01-28T09:38:44 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:38am81.4M
    24th Jan 2025 2025-01-24T10:03:58 Receipt of R&D Tax Incentive RefundYesNo10:03am1255k
    2nd Dec 2024 2024-12-02T08:36:59 Non-deal Investor Roadshow PresentationYesNo8:36am172.4M

    About Resonance Health Ltd

    Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

    RHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    10 Jun 2025 $0.04 $0.00 0.00% 218,140 $0.04 $0.04 $0.04
    05 Jun 2025 $0.04 $0.00 0.00% 25,577 $0.04 $0.04 $0.04
    04 Jun 2025 $0.04 $0.00 0.00% 106,390 $0.04 $0.04 $0.04
    03 Jun 2025 $0.04 $0.00 0.00% 510,008 $0.04 $0.04 $0.04
    30 May 2025 $0.04 $0.00 0.00% 21,703 $0.04 $0.04 $0.04
    29 May 2025 $0.04 $0.00 0.00% 83,539 $0.04 $0.04 $0.04
    28 May 2025 $0.04 $0.00 0.00% 40,000 $0.04 $0.04 $0.04
    27 May 2025 $0.04 $0.00 0.00% 31,569 $0.04 $0.04 $0.04
    23 May 2025 $0.04 $0.00 0.00% 315,768 $0.04 $0.04 $0.04
    22 May 2025 $0.04 $0.00 0.00% 20,133 $0.04 $0.04 $0.04
    21 May 2025 $0.04 $0.00 0.00% 20 $0.04 $0.04 $0.04
    20 May 2025 $0.04 $0.00 0.00% 33,293 $0.04 $0.04 $0.04
    19 May 2025 $0.04 $0.00 0.00% 406,571 $0.04 $0.04 $0.04
    15 May 2025 $0.04 $0.00 0.00% 9,396 $0.04 $0.04 $0.04
    13 May 2025 $0.04 $0.00 0.00% 120,000 $0.04 $0.04 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    09 Apr 2025 Aaron Brinkworth Buy 259,475 $520
    On-market trade.
    08 Apr 2025 Aaron Brinkworth Buy 267,083 $19,454
    On-market trade.
    07 Apr 2025 Aaron Brinkworth Buy 272,885 $9,959
    On-market trade.
    04 Apr 2025 Aaron Brinkworth Buy 8,204 $303
    On-market trade.
    06 Nov 2024 Mitchell Wells Exercise 610,000 $27,460
    Conversion of securities. 610,000 PERFORMANCE RIGHTS
    06 Nov 2024 Mitchell Wells Buy 610,000 $27,460
    Conversion of securities.
    25 Jun 2024 Travis Baroni Buy 85,000 $5,015
    On-market trade.
    18 Jun 2024 Travis Baroni Buy 3,320 $199
    On-market trade.
    17 Jun 2024 Travis Baroni Buy 81,680 $4,900
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Martin Peter Blake Non-Executive DirectorNon-Executive Chairman Oct 2007
    Dr Blake is a Radiologist and Nuclear Physician who brings significant technical and industry experience to Resonance Health. He has been a Partner of Perth Radiological Clinic since 1997. He is a member of the Risk Committee.
    Mr Mitchell MacDonald Wells Company SecretaryNon Executive Director Jun 2023
    Mr Wells is an experienced senior executive and a qualified lawyer with commercial and legal experience in Australia, the United States of America and the United Kingdom.
    Mr Simon Panton Non-Executive Director Oct 2009
    Mr Panton brings skills in business and marketing having run his own successful business. He is a member of the Risk Committee.
    Dr Travis Baroni Non-Executive Director Nov 2016
    Dr Baroni has broad experience across industrial research, commercialisation of technology, asset valuations and investment banking services. He has worked in investment banking, providing advisory services to equity capital market transactions, corporate research and valuations to clients. He is Chair of the Risk Committee.
    Mr Aaron Brinkworth Non-Executive Director Mar 2023
    Mr Brinkworth had a 22-year career with Gilead Sciences, Inc. during which time the company grew from a small biotech-pharma company to a multi-billion-dollar global company with annual sales of over USD $27 billion. He held several commercial, licensing, and patient access roles at Gilead, including that of Executive Director - Global Patient Solutions, where he was responsible for commercial and access strategies for emerging markets.
    Mr Andrew Duncan Harrison Chief Executive Officer Jul 2023
    -
    Andrew Duncan Harrison Chief Executive Officer
    -
    Benjamin Carruthers Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Southam Investments 2003 Pty Ltd <Warwickshire Investment A/C> 74,300,000 16.63%
    HSBC Custody Nominees (Australia) Limited 49,401,078 11.05%
    Mr Paul John Van Dyk 9,250,031 2.07%
    Mr Andrew Duncan Harrison & Mrs Katrina Ellen Harrison <Harrison Super Fund A/C> 8,000,000 1.79%
    Mr William Murray Thompson 6,658,660 1.49%
    Ms Jade Louise Thompson 6,512,759 1.46%
    Mr Harish Garg 6,500,000 1.45%
    Mr Bruce Alan Stevenson 6,400,000 1.43%
    Mr Paul Andrew Fitzmaurice & Mrs Tania Marie Fitzmaurice <Fitzmaurice Family S/F A/C> 5,250,000 1.17%
    Marcolongo Nominees Pty Ltd <Marcolongo Family A/C> 5,186,200 1.16%
    Mr Helmut Rocker 5,000,000 1.12%
    Mr Thomas Psarakis 4,434,777 0.99%
    Mr Evan George Cross & Mrs Donna Sharon Cross <Dec Superannuation Fund A/C> 4,000,000 0.90%
    Dr Martin Peter Blake 3,798,590 0.85%
    Dr Russell Kay Hancock 3,782,704 0.85%
    The University Of Western Australia 3,478,750 0.78%
    Morgan Stanley Australia Securities (Nominee) Pty Limited (No 1 Account) 3,305,746 0.74%
    Neweconomy Com Au Nominees Pty Limited (900 Account) 3,197,656 0.72%
    Cornucopia Assets Pty Ltd <Cornucopia Super Fund A/C> 3,140,000 0.70%
    Mr Robert Francis Panton 2,800,000 0.63%

    Profile

    since

    Note